Clarity Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.3M Sell
11,883
-59
-0.5% -$20.2K 0.76% 29
2026
Q1
$4.2M Buy
11,942
+5
+0% +$1.78K 0.86% 29
2025
Q4
$3.91M Buy
+11,937
New +$3.79M 0.8% 31
2023
Q1
Sell
-945
Closed -$248K 75
2022
Q4
$248K Sell
945
-4
-0.4% -$1.07K 0.14% 60
2022
Q3
$213K Sell
949
-14
-1% -$3.39K 0.13% 58
2022
Q2
$234K Sell
963
-5
-0.5% -$1.23K 0.13% 60
2022
Q1
$234K Sell
968
-5
-0.5% -$1.15K 0.11% 63
2021
Q4
$218K Sell
973
-1
-0.1% -$211 0.1% 66
2021
Q3
$207K Sell
974
-11
-1% -$2.53K 0.1% 64
2021
Q2
$240K Buy
985
+15
+2% +$3.69K 0.12% 55
2021
Q1
$241K Buy
+970
New +$231K 0.14% 53

Other funds holding AMGN

Clarity Wealth Advisors's AMGN Position: Q2 2026 in Review

Clarity Wealth Advisors reduced its Amgen (AMGN) stake by 0.49% in Q2 2026, selling an estimated $20.2K and leaving 11,883 shares worth $4.3M. The position accounts for 0.76% of the portfolio, ranked #29.

Clarity Wealth Advisors first reported a position in AMGN in Q1 2021 and has held it in 11 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Clarity Wealth Advisors held 11,883 shares of Amgen worth $4.3M as of Q2 2026.
  • Clarity Wealth Advisors sold 59 Amgen shares in Q2 2026, an estimated $20.2K.
  • Amgen made up 0.76% of Clarity Wealth Advisors's portfolio in Q2 2026, its #29 holding.
  • Clarity Wealth Advisors first reported a position in Amgen in Q1 2021 and has held it in 11 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Clarity Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.